Mirador Capital Partners »

Cytokinetics shares owned by Mirador Capital Partners

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Mirador Capital Partners from 13F filings

Historical chart of Mirador Capital Partners investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Mirador Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5M 36k 70.11
2023-12-31 $4.1M 49k 83.49
2023-09-30 $1.6M 56k 29.46
2023-06-30 $1.8M 54k 32.62
2023-03-31 $2.0M 57k 35.19
2022-12-31 $2.7M 59k 45.82
2022-09-30 $6.2M 129k 48.45
2022-06-30 $6.4M 164k 39.29
2022-03-31 $5.9M 160k 36.81
2021-12-31 $7.0M 153k 45.58
2021-09-30 $5.8M 164k 35.74
2021-06-30 $3.1M 159k 19.79
2021-03-31 $3.5M 149k 23.26
2020-12-31 $3.2M 152k 20.78
2020-09-30 $2.4M 112k 21.65
2020-06-30 $2.3M 96k 23.57
2020-03-31 $1.6M 97k 16.63
2019-12-31 $1.1M 103k 10.61